Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

Clinical trial NCT07572175 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07572175
Sponsor: Icahn School of Medicine at Mount Sinai
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anthracycline-induced Cardiotoxicity Lymphoma Chemotherapy Cardiotoxicity

Start date: 2026-07-01
Primary completion: 2029-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.